Search results
Roche (RHHBY) Posts Encouraging Phase I Obesity Drug Data
Zacks via Yahoo Finance· 9 hours agoData from the study shows that nearly half of the patients who received Roche's (RHHBY)...
Roche's experimental obesity drug shows promising early stage results
United Press International via Yahoo News· 3 hours agoSwiss drug company Roche on Thursday said its experimental obesity treatment helped people lose a...
Roche ramps up obesity-drug competition with early-stage trial results
Market Watch· 10 hours agoThe race to develop powerful new weight-loss drugs grew even more heated on Thursday as Roche...
Roche shares jump on obesity drug results from early-stage trial
Reuters via Yahoo News· 15 hours ago(Reuters) -Roche shares gained as much as 4.7% on Thursday after an early-stage trial showed that a...
Roche stock jumps as obesity drug shows 'encouraging results' in Phase I trial By Investing.com
Investing.com· 14 hours agoRoche stock jumps as obesity drug shows 'encouraging results' in Phase I trial
Roche To Ride Booming Obesity Treatment Market With Newly-Acquired Drug Candidate
Benzinga· 4 hours agoThursday, Genentech, a unit of Roche Holdings AG RHHBY, released results from the Phase 1b trial of...
Roche says weight loss drug shows promising results in early trial
CNBC· 9 hours agoRoche on Thursday said its experimental weight loss drug showed promising results in an early-stage...
Experimental obesity drug packs double punch to reduce weight
Nature· 2 days agoTest of weight-loss candidate in mice shows that there is still room for improvement in a burgeoning...
Investors put $400M into biotech licensing obesity drugs from China
BioPharma Dive via Yahoo Finance· 7 hours agoThe biotech, tentatively named Hercules CM Newco, has rights to three incretin drugs discovered by...
Health Care Flat as Momentum Wanes -- Health Care Roundup
Market Watch· 1 hour agoHealth-care companies were flat as momentum in the sector stalled. Obesity drug maker Novo Nordisk and Eli Lilly gave back some of their recent gains. Omeros...